Trigger for PGx-testing
n patients
n patients with ≥1 ”required” or “recommended” PGx variant1
n SONOGEN XP recommendations2 per patient median (range) n highlighted clinical expert recommendations3 per patient median (range)
Specific PGx drug 102 88 (86.3%) 2 (2-11) 2 (0-6)
Screening 33 29 (87.9%) 5 (3 - 9) 3 (1 - 5)
All Patients 135 117 (86.7 %) 5 (2 - 11) 3 (0 - 6)